This podcast episode examines CAR T-cell therapy’s early successes, broader promise, and emerging risks, as the FDA considers reports of occasional secondary cancers.

中文翻译：

---

CAR T 细胞和安全信号

本播客节目探讨了 CAR T 细胞疗法的早期成功、更广泛的前景以及新出现的风险，同时 FDA 正在考虑偶发性继发性癌症的报告。